On Jun 26, 2021, we received the good news from Elsevier that Therapeutic Radiology and Oncology (TRO) has been accepted for inclusion in Scopus.
Therapeutic Radiology and Oncology (Ther Radiol Oncol; TRO; 2616-2768), launched in September 2017 and originated in 1994 and known in the field as the Blue Journal, publishes papers describing original research, case reports and clinical investigations related to radiation oncology. This includes clinical radiotherapy, radiobiology, chemotherapy, immunotherapy, hyperthermia, tumor biology, experimental therapeutics and clinical oncology. It also covers fields of medical physics, radiology, nursing care, education, technology, health information and health policy as it relates to radiology and oncology.
We can’t achieve this without the continuous support and contributions of TRO’s editorial board members, guest editors, authors, reviewers and readers. We here would like to extend our sincere gratitude to all the contributors. We will keep striving to publish high-quality articles and make TRO to the forefront.